Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.74 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.63 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | KIF11 | P52732 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19097991 | 0.86 | EPHX2 (0.59) | HPGDEPHX2CYP19A1CYP3A4ATM | |
| SCHEMBL21933257 | 0.83 | EPHX2 (0.55) | HPGDEPHX2CYP19A1CYP3A4ATM | |
| SCHEMBL21998482 | 0.82 | HPGD (0.56) | HPGDEPHX2CYP19A1CYP3A4ATM | |
| SCHEMBL14358426 | 0.81 | HPGD (0.68) | HPGDALDH1A1POLBMAPTMEN1 | |
| SCHEMBL14358427 | 0.81 | HPGD (0.68) | HPGDALDH1A1POLBMAPTMEN1 | |
| SCHEMBL21933263 | 0.80 | EPHX2 (0.52) | HPGDEPHX2CYP19A1CYP3A4ATM | |
| SCHEMBL21933266 | 0.80 | LMNA (0.63) | HPGDEPHX2ALDH1A1LMNAPOLB | |
| SCHEMBL19097995 | 0.79 | HPGD (0.73) | HPGDEPHX2CYP19A1ALDH1A1LMNA | |
| SCHEMBL21933253 | 0.79 | GAA (0.58) | HPGDEPHX2CYP19A1ALDH1A1LMNA | |
| SCHEMBL21933291 | 0.77 | EPHX2 (1.00) | EPHX2CYP19A1ALDH1A1KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10829466-B2 | Stilbene derivative and preparation method thereof | BEIJING INSTITUTE OF TECHNOLOGY (CN) | 2020-11-10 | — | — | US | disclosed |
| US-20200148662-A1 | NOVEL STILBENE DERIVATIVE AND PREPARATION METHOD THEREOF | BEIJING INSTITUTE OF TECHNOLOGY (CN) | 2020-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10829466-B2 | Stilbene derivative and preparation method thereof | STS, F12, GLB1 | HPGD 2632/4885EPHX2 3414/4885CYP19A1 144/4885 |
| US-20200148662-A1 | NOVEL STILBENE DERIVATIVE AND PREPARATION METHOD THEREOF | STS, F12, STK38L | HPGD 3123/4885EPHX2 3354/4885CYP19A1 141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.